Gibson Christopher 4

What Happened
Christopher Gibson, a director of Recursion Pharmaceuticals (RXRX), had 22,821 shares withheld on May 15, 2026 to satisfy tax withholding in connection with the net settlement of restricted stock units (RSUs). The withholding price was $3.04 per share, for a total value of approximately $69,376. This transaction is a disposition via tax withholding (transaction code F), a routine administrative event rather than an open‑market sale.

Key Details

• Transaction date: May 15, 2026; Form 4 filed May 19, 2026.
• Shares withheld/disposed: 22,821 at $3.04 per share; total value ≈ $69,376.
• Transaction code: F — shares withheld to satisfy tax withholding on RSU net settlement (see footnote F1).
• Shares owned after transaction: Not specified in this filing.
• Notable footnotes in the filing: F1 (withholding to satisfy tax obligations). Other footnotes (F2–F10) in the filing describe share class conversion rights, holdings through LLCs/trust, and various option vesting schedules for the reporting person.

Context
Net settlement/tax withholding of RSUs means a portion of vested shares are surrendered to the company to cover taxes; these are administrative dispositions and are common after vesting. Such withholdings generally do not signal insider sentiment in the same way that open‑market purchases might.